Meireles Sibele Inácio, Cruz Mariana Vargas, Irffi Gustavo Palmer, Testagrossa Leonardo Abreu
Hospital Sírio Libanês, São Paulo, SP, Brazil.
Hospital Sírio Libanês, São Paulo, SP, Brazil.
Clinics (Sao Paulo). 2024 Dec 27;80:100564. doi: 10.1016/j.clinsp.2024.100564. eCollection 2025.
Mycobacteria infections are caused by species of the Mycobacterium tuberculosis complex (MTB) and other species called Non-Tuberculosis Mycobacteria (NTM). Identification of mycobacteria species is very important to define treatment and it can be achieved by direct culture. However, the lack of clear protocols regarding the use of culture or molecular tests on specimens diagnosed with granulomatous lesions causes delays in the diagnosis of the etiological agents and, consequently, the definition of the right treatment. This work aimed to characterize the incidence of mycobacteria species in pulmonary granulomatous lesions and the contribution of Polymerase Chain Reaction (PCR) in Formalin-Fixed Paraffin-Embedded Tissue (FFPE), direct culture, and Ziehl-Neelsen histological stain to the diagnosis. The authors performed an observational, centralized, and retrospective study in a cohort of 336 cases with pulmonary granulomatous lesions. Mycobacteria were detected by ZNS in 54/323 (16.72 %) and by direct culture in 40/198 (20.20 %). MTB DNA was detected by PCR in 10/57 (17.54 %). Mycobacterial culture results revealed MTB in 26/40 (65.00 %), whereas NTM was detected in 13/40 (32.50 %). NTM was represented by M. avium (n = 4), M. intracellulare (n = 3), M. kansasii (n = 3), M. colombiense (n = 1), M. paraffinicum (n = 1), and M. abscessus subsp. massiliense (n = 1). In conclusion, this study demonstrated that mycobacteria are detected in 16.72 % to 20.20 % of pulmonary granulomatous lesions. Moreover, MTB and NTM were detected in these lesions. The use of different methods for mycobacteria detection, in addition to culture, is complementary and contributes to fastening and increasing the detection of mycobacteria in these lesions.
分枝杆菌感染由结核分枝杆菌复合群(MTB)的菌种以及其他称为非结核分枝杆菌(NTM)的菌种引起。分枝杆菌菌种的鉴定对于确定治疗方案非常重要,可通过直接培养来实现。然而,对于诊断为肉芽肿性病变的标本,缺乏关于使用培养或分子检测的明确方案,导致病原体诊断延迟,进而延误正确治疗方案的确定。本研究旨在描述肺部肉芽肿性病变中分枝杆菌菌种的发生率,以及聚合酶链反应(PCR)在福尔马林固定石蜡包埋组织(FFPE)、直接培养和萋-尼氏组织学染色对诊断的贡献。作者对336例肺部肉芽肿性病变病例进行了一项观察性、集中式回顾性研究。通过萋-尼氏染色在54/323例(16.72%)中检测到分枝杆菌,通过直接培养在40/198例(20.20%)中检测到分枝杆菌。通过PCR在10/57例(17.54%)中检测到MTB DNA。分枝杆菌培养结果显示,40例中有26例(65.00%)为MTB,而13例(32.50%)检测到NTM。NTM包括鸟分枝杆菌(n = 4)、胞内分枝杆菌(n = 3)、堪萨斯分枝杆菌(n = 3)、哥伦比亚分枝杆菌(n = 1)、石蜡分枝杆菌(n = 1)和脓肿分枝杆菌马西利亚亚种(n = 1)。总之,本研究表明,在16.72%至20.20%的肺部肉芽肿性病变中检测到分枝杆菌。此外,在这些病变中检测到了MTB和NTM。除培养外,使用不同方法检测分枝杆菌具有互补性,有助于加快和增加这些病变中分枝杆菌的检测。